David H. Johnston

TL;DR: This work demonstrates the feasibility of a recombinant virus vaccine containing the rabies glycoprotein gene for immunization of raccoons, and possibly other wildlife, to obtain long-term protection against rabies.

TL;DR: In 1995, the last bovine and companion animal cases were reported and in 1996 the last rabid skunk occurred, and only bat variants of rabies were present until 1999, when the raccoon variant entered from New York (USA).

TL;DR: A vaccinia recombinant virus vaccine (V-RG) expressing the ERA (Evelyn-Rokitnicki-Abelseth) rabies virus glycoprotein was highly immunogenic for laboratory animals and raccoons by the intradermal, intramuscular, and oral routes.

TL;DR: The aerial distribution system is capable of economically reaching a high proportion of foxes, skunks, and raccoons over large areas and trials with attenuated ERA (Evelyn-Rokitnicki-Abelseth) vaccines are under way in Ontario.

TL;DR: The rapidity with which foxes picked up their first bait appeared more affected by unknown characteristics of years or study areas than by experimental variables, which has potential for field control of rabies, although higher acceptance will be desirable.